Home > Healthcare > Medical Devices > Diagnostic Devices > Point of Care Testing Market

Point of Care Testing Market Share

Report ID: GMI3086
Published Date: Jul 2023
Report Format: PDF

Download Free Sample

Point of Care Testing Market Share

The competitive analysis of the point of care testing market includes prominent companies

Becton
Dickinson and Company
Abbott Laboratories
F. Hoffmann-La Roche
Abaxis
ACON Laboratories
BioMerieux SA
Bio-Rad Laboratories Inc
HemoCue AB (Danaher Corporation)
Dexcom, Inc
Medtronic Plc
Meridian Bioscience
Trinity Biotech
Nova Biomedical
OraSure Technologies
LifeScan IP Holdings LLC
Siemens Healthineers AG
Accubiotech Co Ltd
Sysmex Corporation
Dragerwerk Ag & Co
BioLytical Laboratories Inc.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Point of care testing industry was valued at USD 38.6 billion in 2022 and is estimated to expand at 7% CAGR from 2023 to 2032 owing to the increasing prevalence of infectious diseases across developing countries.

The glucose monitoring segment accounted for 24.9% revenue share of the market in 2022 and is estimated to reach USD 19.2 billion by 2032 driven by the growing adoption of portable, highly convenient, and cost-effective as well as rapid POC glucose tests.

North America held 47.6% share of the market in 2022 and is anticipated to amass more than USD 35.6 billion by 2032 owing to the rising R&D investments and surge in private funding for healthcare infrastructure development.

Some of the top companies engaged in the industry are Becton, Dickinson and Company, Abbott Laboratories, F. Hoffmann-La Roche, Abaxis, ACON Laboratories, Inc, BioMerieux SA, Bio-Rad Laboratories, Inc, HemoCue AB (Danaher Corporation), Dexcom, Inc, and Medtronic Plc,